RxDoctor Payments Data

Thomas Warren, MD

Otolaryngology/Facial Plastic Surgery · Mooresville, NCNPI 1386715639

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Sanofi at 34.8% of the total. 2025 is the largest year on record at $505, 4.3 times the $116 reported in 2019.

$1,462in general payments, 2019–2025

Across 61 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$509
  • Regeneron Healthcare Solutions, Inc.$290
  • GSK$279
  • Stryker$136
  • Acclarent, Inc$55
  • Optinose US, Inc.$31
  • plus $162 from 9 others

What the payments were for

  • Food & beverage$1,462100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$166,078
Medicare patients
357
Services billed
2,873

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone12$1,905
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,776
Famotidine137$1,487
Azelastine Hcl56$1,406
Doxycycline Monohydrate97$1,260
Ipratropium Bromide38$809
Fluticasone Propionate43$799
Montelukast Sodium87$681
Gabapentin29$582
Mometasone Furoate12$513
Mupirocin67$479
Fluocinolone Acetonide Oil12$430
Ofloxacin21$398
Omeprazole57$395
Pantoprazole Sodium11$373

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →